atezolizumab,xl092
exelixis,roche
['xl092', 'xl092 ', 'stellar-001', 'solid tumor', 'exelixis', '$exel']
$exel exelixis announces dose-escalation results from the phase 1 stellar-001 trial evaluating xl092 alone and in combination with an immune checkpoint inhibitor in patients with advanced solid tumors at esmo 2022 45 seconds delayed.
Democratizing insights.

Not investment advice.